Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Cribbs

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
CNS & Neurological Disorders Drug Targets|March 9, 2010
Abeta DNA vaccination for Alzheimer's disease: focus on disease preventionDavid H Cribbs
Neurochemistry International|June 13, 2006
Novel approaches for immunotherapeutic intervention in Alzheimer's diseaseVitaly Vasilevko, David H Cribbs
CNS & Neurological Disorders Drug Targets|March 12, 2009
Active and passive Abeta-immunotherapy: preclinical and clinical studies and future directions: part IMichael G Agadjanyan, David H Cribbs
CNS & Neurological Disorders Drug Targets|April 10, 2009
Active and passive Abeta-immunotherapy: preclinical and clinical studies and future directions: part IIDavid H Cribbs, Michael G Agadjanyan
Translational Stroke Research|June 19, 2012
Mixed cerebrovascular disease and the future of stroke preventionMark Fisher, Vitaly Vasilevko, David H Cribbs
Journal of Alzheimer'S Disease : JAD|July 28, 2007
Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's diseaseMilan Fiala, David H Cribbs, Mark Rosenthal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 15, 2009
Immunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse modelMasashi Kitazawa, Vitaly Vasilevko, David H Cribbs, et al.
Eneuro|April 5, 2017
Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's DiseaseLisa Kirouac, Alexander J Rajic, David H Cribbs, et al.
The American Journal of Pathology|July 28, 2004
Caspase-mediated degeneration in Alzheimer's diseaseDavid H Cribbs, Wayne W Poon, Robert A Rissman, et al.
Neuron|August 6, 2004
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasomeSalvatore Oddo, Lauren Billings, J Patrick Kesslak, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
CNS & Neurological Disorders Drug Targets|March 9, 2010
Abeta DNA vaccination for Alzheimer's disease: focus on disease preventionDavid H Cribbs
Neurochemistry International|June 13, 2006
Novel approaches for immunotherapeutic intervention in Alzheimer's diseaseVitaly Vasilevko, David H Cribbs
CNS & Neurological Disorders Drug Targets|March 12, 2009
Active and passive Abeta-immunotherapy: preclinical and clinical studies and future directions: part IMichael G Agadjanyan, David H Cribbs
CNS & Neurological Disorders Drug Targets|April 10, 2009
Active and passive Abeta-immunotherapy: preclinical and clinical studies and future directions: part IIDavid H Cribbs, Michael G Agadjanyan
Translational Stroke Research|June 19, 2012
Mixed cerebrovascular disease and the future of stroke preventionMark Fisher, Vitaly Vasilevko, David H Cribbs
Journal of Alzheimer'S Disease : JAD|July 28, 2007
Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's diseaseMilan Fiala, David H Cribbs, Mark Rosenthal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 15, 2009
Immunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse modelMasashi Kitazawa, Vitaly Vasilevko, David H Cribbs, et al.
Eneuro|April 5, 2017
Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's DiseaseLisa Kirouac, Alexander J Rajic, David H Cribbs, et al.
The American Journal of Pathology|July 28, 2004
Caspase-mediated degeneration in Alzheimer's diseaseDavid H Cribbs, Wayne W Poon, Robert A Rissman, et al.
Neuron|August 6, 2004
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasomeSalvatore Oddo, Lauren Billings, J Patrick Kesslak, et al.
Pageof 13